# Proton Beam Therapy and the AYA Sarcoma Patient Journey: Highlighting Needs from Diagnosis to Survivorship

## TL;DR

This paper reviews the unique challenges faced by young sarcoma patients and the underutilized benefits of proton beam therapy in their treatment journey.

## Contribution

The paper emphasizes the need for proton beam therapy and holistic care in adolescent and young adult sarcoma patients.

## Key findings

- Proton beam therapy reduces long-term toxicities in AYA sarcoma patients.
- AYA patients face unique physical, mental, and social challenges during treatment.
- There is a need for improved care strategies that consider the whole person.

## Abstract

A sarcoma diagnosis is devastating at any period in life but can be particularly disruptive to those who are still in the stages of development. An adolescent and young adult (AYA) patient has been defined as a patient aged 15–39 at the time of diagnosis. Research has proven this patient population to be unique through the exploration of challenges and needs that positively impact outcomes. Proton beam therapy (PBT) is a component of cancer care that has been found to be underutilized in the AYA patient population. This review will highlight research that has been completed that supports the use of PBT, present the many challenges that this unique patient population faces, discuss interventions that have been utilized, and present opportunities for growth to better serve an AYA sarcoma patient.

Background: Adolescents and young adults (15–39 years of age at time of diagnosis: AYA) with sarcoma are a unique patient population. The objective of this review is to examine the literature outlining the benefits of proton beam therapy (PBT) for treatment of AYA sarcoma patients, barriers to PBT, evaluation of AYA-specific considerations and challenges, and exploration of future opportunities for improvements in care. Methods: An electronic search was conducted using databases and online search engines, primarily PubMed. The search criteria included studies and reviews completed from 2015 to 2025. Results: 57 articles were reviewed and categorized into sections: PBT for the treatment of the AYA patient, barriers to PBT, AYA-specific considerations and challenges, and future directions for the care of an AYA patient. Conclusions: Through this review, PBT can be deemed necessary when treating AYA sarcoma patients with radiation therapy to decrease long-term therapy-related toxicities. Furthermore, considerations for caring for an AYA sarcoma patient must extend beyond evidence-based treatment plans and must embrace the patient as a whole person through acknowledgement of the challenging impact on physical, mental, and social well-being from symptoms to diagnosis, diagnosis to treatment, and treatment to survivorship.